{"id":"gadoterate-meglumine-dotarem","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (pain, erythema)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nephrogenic systemic fibrosis (NSF) in patients with severe renal impairment"}]},"_chembl":{"chemblId":"CHEMBL2219415","moleculeType":"Small molecule","molecularWeight":"753.86"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Gadoterate meglumine is a macrocyclic gadolinium chelate complex that distributes in the extracellular space and increases the relaxivity of nearby water molecules, thereby enhancing tissue contrast on T1-weighted MRI images. The gadolinium ion is tightly bound within a cyclic ligand structure, which improves safety by reducing the risk of gadolinium release and deposition in tissues compared to linear chelates.","oneSentence":"Gadoterate meglumine is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the relaxation time of water protons in tissues.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:13:36.929Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"MRI contrast enhancement for central nervous system imaging"},{"name":"MRI contrast enhancement for body imaging including liver, kidney, and other organs"}]},"trialDetails":[{"nctId":"NCT03730051","phase":"PHASE4","title":"Dotarem vs Gadobutrol Contrast for Breast MRI","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-03-01","conditions":"Breast Diseases","enrollment":300},{"nctId":"NCT06252493","phase":"","title":"Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-19","conditions":"Crohn Disease","enrollment":25},{"nctId":"NCT06057168","phase":"PHASE3","title":"Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas","status":"COMPLETED","sponsor":"Guerbet","startDate":"2023-09-07","conditions":"Brain Tumor, Primary, Brain Tumor, Recurrent","enrollment":138},{"nctId":"NCT04373564","phase":"PHASE4","title":"Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years","status":"RECRUITING","sponsor":"Guerbet","startDate":"2021-03-24","conditions":"Motor Function, Cognitive Function, Contrast Media","enrollment":2076},{"nctId":"NCT07348640","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease","status":"NOT_YET_RECRUITING","sponsor":"Guerbet","startDate":"2026-02-02","conditions":"Steno-occlusive Disease","enrollment":315},{"nctId":"NCT05915728","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":"Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology","enrollment":404},{"nctId":"NCT05937776","phase":"","title":"Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2023-12-11","conditions":"Glioma","enrollment":20},{"nctId":"NCT06265272","phase":"","title":"Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-10","conditions":"Liver Cirrhosis, Hepatic Cell Carcinoma, Portal Hypertension","enrollment":45},{"nctId":"NCT05915702","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":"Contrast Enhancement in Magnetic Resonance Imaging, Central Nervous System Pathology","enrollment":303},{"nctId":"NCT02382380","phase":"PHASE4","title":"Evaluation of Gadoterate in Patients With Renal Dysfunction","status":"TERMINATED","sponsor":"Loyola University","startDate":"2014-11-05","conditions":"Renal Dysfunction","enrollment":46},{"nctId":"NCT06754956","phase":"NA","title":"Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University Affiliated Sixth People's Hospital","startDate":"2025-01-10","conditions":"High Resolution Vessel Wall Imaging, Intracranial Atherosclerotic Stenosis, ICAS, Arteriosclerosis","enrollment":100},{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":"Alzheimer Disease, Early Onset","enrollment":6},{"nctId":"NCT05417776","phase":"PHASE2","title":"Collagen-targeted PET Imaging for Early Interstitial Lung Disease","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-09-28","conditions":"Interstitial Lung Disease","enrollment":30},{"nctId":"NCT06267807","phase":"NA","title":"Lymphatic Phenotype in Noonan Syndrome Spectrum Disorders","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2024-03-27","conditions":"Lymphatic System Disorders Congenital, Lymphatic Diseases, Noonan Syndrome","enrollment":9},{"nctId":"NCT06532071","phase":"PHASE2","title":"Advanced Imaging for Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Peter Caravan","startDate":"2025-01-21","conditions":"Pulmonary Fibrosis","enrollment":60},{"nctId":"NCT05855941","phase":"","title":"Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)","status":"RECRUITING","sponsor":"Region Västerbotten","startDate":"2023-05-23","conditions":"Cervix Cancer, Endometrial Cancer, Epithelial Ovarian Cancer","enrollment":120},{"nctId":"NCT03337594","phase":"","title":"Gadolinium Retention in Human Bone Tissue in Pediatric Patients","status":"COMPLETED","sponsor":"Donna Roberts","startDate":"2017-10-01","conditions":"Gadolinium, MultiHance, Dotarem","enrollment":57},{"nctId":"NCT03937921","phase":"","title":"Dotarem Evaluation for Myocardial Perfusion CMR","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2019-07-03","conditions":"Myocardial Perfusion Imaging, Magnetic Resonance Imaging","enrollment":90},{"nctId":"NCT01514617","phase":"NA","title":"Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2012-01","conditions":"Leiomyomas","enrollment":100},{"nctId":"NCT04341129","phase":"EARLY_PHASE1","title":"Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2020-07-13","conditions":"Breast Neoplasms, Breast Diseases, Breast Fibroadenoma","enrollment":50},{"nctId":"NCT03731923","phase":"NA","title":"Abbreviated MRI for HCC Surveillance","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2018-11-08","conditions":"Hepatocellular Carcinoma, Liver Cirrhosis, Chronic Hepatitis","enrollment":257},{"nctId":"NCT03023566","phase":"","title":"Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI","status":"COMPLETED","sponsor":"Phoenix Children's Hospital","startDate":"2017-02-09","conditions":"Brain Diseases","enrollment":250},{"nctId":"NCT02059551","phase":"NA","title":"Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-08","conditions":"Pulmonary Embolism","enrollment":887},{"nctId":"NCT04552847","phase":"PHASE2, PHASE3","title":"Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2020-10-07","conditions":"Neuroendocrine Tumors","enrollment":85},{"nctId":"NCT05199792","phase":"","title":"Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2017-06-02","conditions":"Vascular Diseases","enrollment":65},{"nctId":"NCT03602339","phase":"PHASE4","title":"Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-11-14","conditions":"Magnetic Resonance Imaging","enrollment":157},{"nctId":"NCT02163005","phase":"PHASE4","title":"A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2016-12","conditions":"Contrast Media Allergy","enrollment":""},{"nctId":"NCT03091803","phase":"","title":"QSM and Regional DCE MRI Permeability Using GOCART Technique","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2017-04-04","conditions":"Intracranial Neoplasm","enrollment":""},{"nctId":"NCT02598674","phase":"","title":"Severe Sepsis in Children - IMPRESS-C","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2019-10","conditions":"Acute Kidney Injury, Chronic Kidney Disease, Hypertension","enrollment":""},{"nctId":"NCT02783768","phase":"EARLY_PHASE1","title":"Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-03-01","conditions":"Pulmonary Disease, Chronic Obstructive, E-cigarettes","enrollment":12},{"nctId":"NCT02234375","phase":"PHASE4","title":"Use of Gadolinium in CT Pulmonary Angiography","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2017-07","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT02899377","phase":"NA","title":"A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-11-18","conditions":"Autoimmune Diseases","enrollment":25},{"nctId":"NCT02609919","phase":"","title":"Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2016-01","conditions":"Adverse Reaction to Drug, Allergic Reaction to Contrast Media","enrollment":150},{"nctId":"NCT01806740","phase":"PHASE4","title":"DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC","status":"TERMINATED","sponsor":"Guerbet","startDate":"2013-05-09","conditions":"Hepatocellular Carcinoma","enrollment":37},{"nctId":"NCT01254552","phase":"PHASE4","title":"Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-08","conditions":"Type 2 Diabetes Mellitus, Coronary Atherosclerosis","enrollment":351},{"nctId":"NCT01211873","phase":"PHASE3","title":"Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-09","conditions":"Diagnostic Self Evaluation, Central Nervous System Diseases","enrollment":416},{"nctId":"NCT03910114","phase":"","title":"Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1990-07-01","conditions":"Magnetic Resonance Imaging Contrast Agents","enrollment":500},{"nctId":"NCT01467271","phase":"","title":"Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration","status":"COMPLETED","sponsor":"Guerbet","startDate":"2011-05","conditions":"Renal Insufficiency","enrollment":540},{"nctId":"NCT03057561","phase":"NA","title":"Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance","status":"UNKNOWN","sponsor":"Dipan Shah","startDate":"2016-10-01","conditions":"Coronary Artery Disease, Cardiomyopathy","enrollment":120},{"nctId":"NCT02286258","phase":"PHASE1, PHASE2","title":"Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2014-10","conditions":"Renal Insufficiency, Chronic, Kidney Diseases","enrollment":166},{"nctId":"NCT03048006","phase":"","title":"Post-marketing Surveillance Study for Evaluation of Dotarem Safety","status":"COMPLETED","sponsor":"Guerbet","startDate":"2011-01","conditions":"Contrast-enhanced MRI With Dotarem","enrollment":44456},{"nctId":"NCT03041298","phase":"","title":"Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography","status":"COMPLETED","sponsor":"Guerbet","startDate":"2011-09","conditions":"MR Mammography With Dotarem","enrollment":1537},{"nctId":"NCT02431598","phase":"PHASE4","title":"Eovist vs. Dotarem Healthy Volunteer MRI","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-06","conditions":"Transient Severe Arterial Phase Motion","enrollment":44},{"nctId":"NCT02411201","phase":"PHASE4","title":"DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years","status":"COMPLETED","sponsor":"Guerbet","startDate":"2015-03","conditions":"Magnetic Resonance Imaging","enrollment":51},{"nctId":"NCT01523873","phase":"","title":"Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)","status":"COMPLETED","sponsor":"Guerbet","startDate":"2008-11","conditions":"General Safety Profile of DOTAREM","enrollment":35921},{"nctId":"NCT02070380","phase":"PHASE4","title":"Crossover Comparison of MultiHance and Dotarem","status":"COMPLETED","sponsor":"Bracco Diagnostics, Inc","startDate":"2014-02","conditions":"Brain Disease","enrollment":179},{"nctId":"NCT02034708","phase":"PHASE4","title":"Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors","status":"COMPLETED","sponsor":"Guerbet","startDate":"2014-06","conditions":"Primary Brain Tumor","enrollment":279},{"nctId":"NCT03000036","phase":"NA","title":"Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2012-07","conditions":"Breast Cancer Female, Doxorubicin Induced Cardiomyopathy","enrollment":27},{"nctId":"NCT02992847","phase":"","title":"Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2017-01","conditions":"Multiple Sclerosis","enrollment":160},{"nctId":"NCT01012674","phase":"PHASE3","title":"Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)","status":"COMPLETED","sponsor":"Guerbet","startDate":"2009-10","conditions":"Cerebral Arterial Diseases","enrollment":211},{"nctId":"NCT01010932","phase":"PHASE3","title":"Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)","status":"COMPLETED","sponsor":"Guerbet","startDate":"2009-10","conditions":"Cerebral Arterial Diseases","enrollment":222},{"nctId":"NCT00980681","phase":"PHASE3","title":"Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)","status":"TERMINATED","sponsor":"Guerbet","startDate":"2009-09","conditions":"Renal Disease","enrollment":13},{"nctId":"NCT00845702","phase":"PHASE3","title":"Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)","status":"TERMINATED","sponsor":"Guerbet","startDate":"2009-04","conditions":"Renal Artery Stenosis","enrollment":33},{"nctId":"NCT02718976","phase":"PHASE2","title":"Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2016-03","conditions":"Hip Fractures, Anesthesia, Local, Pain, Postoperative","enrollment":22},{"nctId":"NCT02593370","phase":"PHASE1","title":"Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block","status":"COMPLETED","sponsor":"Thomas F. Bendtsen","startDate":"2015-10","conditions":"Hip Fractures, Anesthesia Local, Pain, Perioperative","enrollment":26},{"nctId":"NCT02364193","phase":"NA","title":"Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance","status":"COMPLETED","sponsor":"Catharina Ziekenhuis Eindhoven","startDate":"2015-03","conditions":"Pulmonary Congestion","enrollment":14},{"nctId":"NCT01449266","phase":"PHASE1","title":"Safety and Dialysability of Dotarem® in Dialysed Patients","status":"COMPLETED","sponsor":"Guerbet","startDate":"2011-11","conditions":"End-stage Renal Failure","enrollment":10},{"nctId":"NCT01657747","phase":"NA","title":"Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2011-11","conditions":"Ovarian Carcinoma","enrollment":350},{"nctId":"NCT00650845","phase":"PHASE4","title":"Renal Safety Evaluation After Dotarem®-Enhanced MRI","status":"COMPLETED","sponsor":"Guerbet","startDate":"2008-01","conditions":"Renal Insufficiency","enrollment":135},{"nctId":"NCT00764387","phase":"PHASE4","title":"Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-03","conditions":"Neoplastic CNS Lesions","enrollment":166},{"nctId":"NCT01026389","phase":"PHASE4","title":"Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease","status":"COMPLETED","sponsor":"Guerbet","startDate":"2009-10","conditions":"Peripheral Arterial Disease","enrollment":189},{"nctId":"NCT00955617","phase":"PHASE4","title":"DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases","status":"COMPLETED","sponsor":"Guerbet","startDate":"2009-07","conditions":"Peripheral Arterial Disease","enrollment":20},{"nctId":"NCT00538408","phase":"","title":"Whole Body Magnetic Resonance Angiography in Ischemic Patients","status":"UNKNOWN","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2007-09","conditions":"Atherosclerosis, Intermittent Claudication","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Gadoterate meglumine (Dotarem)","genericName":"Gadoterate meglumine (Dotarem)","companyName":"Guerbet","companyId":"guerbet","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gadoterate meglumine is a gadolinium-based contrast agent that enhances magnetic resonance imaging (MRI) by shortening the relaxation time of water protons in tissues. Used for MRI contrast enhancement for central nervous system imaging, MRI contrast enhancement for body imaging including liver, kidney, and other organs.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}